Catheter Precision (VTAK) Net Income towards Common Stockholders (2017 - 2026)
Catheter Precision (VTAK) reported Net Income towards Common Stockholders of -$3.0 million for Q1 2026, up 24.82% year-over-year from -$2.4 million in Q1 2025, and down 14.5% on a QoQ basis from -$2.7 million in Q4 2025.
Catheter Precision (VTAK) has 10 years of Net Income towards Common Stockholders data on file, last reported at -$3.0 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders rose 24.82% year-over-year to -$3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$14.3 million (up 38.32% YoY) and the FY2025 annual result came in at -$17.2 million, up 21.18% from the prior year.
- Net Income towards Common Stockholders eased to -$3.0 million in Q1 2026 per VTAK's latest filing, from -$2.7 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at -$669000.0 in Q4 2023 and bottomed at -$67.2 million in Q1 2023.
- The 5-year median for Net Income towards Common Stockholders is -$4.1 million (2024), against an average of -$8.1 million.
- Peak annual rise in Net Income towards Common Stockholders reached 96.02% in 2024, while the deepest fall reached 1512.26% in 2024.
- Tracing VTAK's Net Income towards Common Stockholders over 5 years: stood at -$8.2 million in 2022, then soared by 91.8% to -$669000.0 in 2023, then sank by 1512.26% to -$10.8 million in 2024, then surged by 75.38% to -$2.7 million in 2025, then slipped by 14.5% to -$3.0 million in 2026.
- Per Business Quant, the three latest VTAK Net Income towards Common Stockholders figures stand at -$3.0 million (Q1 2026), -$2.7 million (Q4 2025), and -$2.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Catheter Precision | 2.01 Mn | 1.20 Mn | 390,000.00 | -3.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.04 Mn |
| Dec 31, 2025 | -7.66 Mn |
| Sep 30, 2025 | -2.27 Mn |
| Jun 30, 2025 | -6.41 Mn |
| Mar 31, 2025 | -4.77 Mn |
| Dec 31, 2024 | -10.79 Mn |
| Sep 30, 2024 | -4.12 Mn |
| Jun 30, 2024 | -4.22 Mn |
| Mar 31, 2024 | -2.68 Mn |
| Dec 31, 2023 | -669,000.00 |
| Sep 30, 2023 | -1.93 Mn |
| Jun 30, 2023 | -1.58 Mn |
| Mar 31, 2023 | -67.20 Mn |
| Dec 31, 2022 | -8.16 Mn |
| Sep 30, 2022 | -4.76 Mn |
| Jun 30, 2022 | -8.45 Mn |
| Mar 31, 2022 | -5.50 Mn |
| Sep 30, 2021 | 3.08 Mn |
| Jun 30, 2021 | -5.25 Mn |
| Mar 31, 2021 | -359,000.00 |
| Dec 31, 2020 | -202,000.00 |
| Sep 30, 2020 | -264,000.00 |
| Jun 30, 2020 | -10.12 Mn |
| Mar 31, 2020 | -7.70 Mn |
| Dec 31, 2019 | -9.74 Mn |
| Sep 30, 2019 | -17.42 Mn |
| Jun 30, 2019 | -15.12 Mn |
| Mar 31, 2019 | -14.67 Mn |
| Dec 31, 2018 | -14.94 Mn |
| Sep 30, 2018 | -4.81 Mn |
| Jun 30, 2018 | -8.40 Mn |
| Mar 31, 2018 | -2.69 Mn |
| Dec 31, 2017 | -3.10 Mn |
| Sep 30, 2017 | -1.72 Mn |